Audevard

Audevard is a France-based company specializing in veterinary health solutions for equines, dedicated to enhancing the health and performance of horses through tailored nutritional products and therapies. Founded in 1985, Audevard focuses on veterinary health, particularly for horses. The company was acquired by Ekkio Capital in February 2015, with financial terms undisclosed. Audevard's headquarters are located in France, serving global markets with a commitment to equine health solutions.

Audevard specializes in veterinary health solutions primarily for equines, focusing on the overall health, performance, and well-being of horses. The company offers a diverse range of products designed to address specific health needs, including digestive support, respiratory comfort, muscle and joint care, and nutritional supplements. Their flagship products, such as Ekygard+ for gastric health and Ekyflex for tendon and joint support, are formulated using a combination of natural ingredients, including plant extracts and probiotics. Audevard's client base consists of veterinarians, horse owners, and breeders, with products being distributed across various international markets, including Europe, North America, and select regions in Asia.

Audevard reported revenues of USD 26. 47 mn for the year 2024, with an EBITDA of USD 5. 10 mn. The company generates revenue through direct sales to veterinarians and horse owners, as well as partnerships with retailers and distributors in the equine health sector, focusing on a transactional model that facilitates streamlined access to products designed for specific health concerns.

Audevard aims to expand its product offerings with new designs targeting innovative equine health solutions. The company is also planning to enter new markets, specifically targeting regions in Asia and North America by 2025. The funding from the acquisition by Ekkio Capital in February 2015 will be leveraged to support these growth initiatives and enhance product development.